Pfizer Inc. (NYSE: PFE) reported first quarter 2023 earnings results today. Revenues declined 29% year-over-year to $18.3 billion. Reported net income fell 30% to $5.5 billion, or $0.97 per share, compared to last year. Adjusted EPS was down 24% to $1.23. Both revenue and earnings beat estimates. For the full year of 2023, Pfizer expects […]
Pfizer Inc. (NYSE: PFE) reported first quarter 2023 earnings results today. Revenues declined 29% year-over-year to $18.3 billion. Reported net income fell 30% to $5.5 billion, or $0.97 per share, compared to last year. Adjusted EPS was down 24% to $1.23. Both revenue and earnings beat estimates. For the full year of 2023, Pfizer expects […]
Pfizer Inc. (NYSE: PFE) reported first quarter 2023 earnings results today.
Revenues declined 29% year-over-year to $18.3 billion.
Reported net income fell 30% to $5.5 billion, or $0.97 per share, compared to last year. Adjusted EPS was down 24% to $1.23.
Both revenue and earnings beat estimates.
For the full year of 2023, Pfizer expects revenue of $67-71 billion.
